Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
Phase 1/2 Terminated
19 enrolled 11 charts
Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps
Phase 1/2 Terminated
8 enrolled 8 charts
DUART
Phase 1/2 Terminated
26 enrolled 20 charts
Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer
Phase 1/2 Terminated
25 enrolled 18 charts
Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632)
Phase 1/2 Terminated
15 enrolled 9 charts
Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma
Phase 1/2 Terminated
8 enrolled 16 charts
A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer
Phase 1/2 Terminated
32 enrolled
A Study of PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer
Phase 1/2 Terminated
12 enrolled
MnSOD
Phase 1/2 Terminated
18 enrolled 12 charts
Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma
Phase 1/2 Terminated
14 enrolled
Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer
Phase 1/2 Terminated
32 enrolled 18 charts
Study of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell Lymphoma
Phase 1/2 Terminated
29 enrolled 16 charts
VTX-2337 in Combination With Radiotherapy in Patients Low-Grade B-cell Lymphomas
Phase 1/2 Terminated
2 enrolled 4 charts
Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics
Phase 1/2 Terminated
44 enrolled 6 charts
A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer
Phase 1/2 Terminated
23 enrolled 18 charts
Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By Surgery
Phase 1/2 Terminated
5 enrolled 11 charts
Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas
Phase 1/2 Terminated
10 enrolled 12 charts
Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma
Phase 1/2 Terminated
4 enrolled
Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer
Phase 1/2 Terminated
8 enrolled 4 charts
Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer
Phase 1/2 Terminated
3 enrolled
Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer
Phase 1/2 Terminated
Stage I/II Nasal NK Cell Lymphoma
Phase 1/2 Terminated
1 enrolled 3 charts
Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC
Phase 1/2 Terminated
13 enrolled 15 charts
Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma
Phase 1/2 Terminated
7 enrolled
Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT
Phase 1/2 Terminated
30 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
Phase 1/2 Terminated
36 enrolled
Vorinostat Plus Radiation Therapy in Pancreatic Cancer
Phase 1/2 Terminated
3 enrolled 3 charts
Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer
Phase 1/2 Terminated
4 enrolled
Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer
Phase 1/2 Terminated
34 enrolled
Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer
Phase 1/2 Terminated
29 enrolled